So-Young International (SY) Gains from Sales and Divestitures (2024 - 2025)
So-Young International (SY) posted Gains from Sales and Divestitures of $412132.2 for Q4 2025, up 1.28% on a QoQ basis from $406927.5 in Q4 2024, and up 1.28% year-over-year from $406927.5 in Q4 2024.
So-Young International (SY) has 2 years of Gains from Sales and Divestitures data on file, last reported at $412132.2 in Q4 2025.
- In Q4 2025, Gains from Sales and Divestitures rose 1.28% year-over-year to $412132.2; the TTM figure through Dec 2025 stood at $412132.2 (up 1.28% YoY), while the FY2025 annual figure was $412132.2, up 1.31% from the prior year.
- Gains from Sales and Divestitures improved to $412132.2 in Q4 2025, from $406927.5 in the prior quarter.
- Across five years, Gains from Sales and Divestitures topped out at $412132.2 in Q4 2025 and bottomed at $406927.5 in Q4 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Veeva Systems | 30.85 Bn | 24.28 Bn | 622.47 Mn |
| 2 | BrightSpring Health Services | 12.29 Bn | 11.41 Bn | 482.22 Mn |
| 3 | Healthequity | 7.80 Bn | 7.48 Bn | 256.31 Mn |
| 4 | Hinge Health | 4.82 Bn | 4.51 Bn | 154.23 Mn |
| 5 | Doximity | 4.21 Bn | 3.46 Bn | 125.97 Mn |
| 6 | Waystar Holding | 4.18 Bn | 4.03 Bn | 268.04 Mn |
| 7 | 10x Genomics | 3.78 Bn | 3.24 Bn | 106.18 Mn |
| 8 | Privia Health | 2.65 Bn | 2.28 Bn | 595.71 Mn |
| 9 | Omnicell | 1.95 Bn | 1.78 Bn | 140.36 Mn |
| 10 | So-Young International | 28.43 Mn | -78.18 Mn | 26.35 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 412,132.23 |
| Dec 31, 2025 | 412,132.23 |
| Dec 31, 2024 | 406,927.55 |
| Dec 31, 2024 | 406,927.55 |